首頁 > 市場調查報告書 > 醫療設備

病患監測行動醫療

皮膚微流體貼片市場規模、佔有率和成長分析：按產品類型、技術類型、應用、生物標記類型、材料類型、最終用戶、分銷管道和地區分類 - 2026-2033 年行業預測

市場調查報告書

商品編碼

1964363

皮膚微流體貼片市場規模、佔有率和成長分析：按產品類型、技術類型、應用、生物標記類型、材料類型、最終用戶、分銷管道和地區分類 - 2026-2033 年行業預測

Lab-On-Skin Microfluidic Patch Market Size, Share, and Growth Analysis, By Product Type, By Technology Type, By Application, By Biomarker Type, By Material Type, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球皮膚微流體貼片實驗室市值為13.4億美元，預計將從2025年的15.7億美元成長到2033年的56.8億美元。預測期（2026-2033年）的複合年成長率預計為17.4%。

皮膚微流體貼片市場的發展動力源於微型化流體技術的融合以及對連續非侵入性生理監測日益成長的需求。這些創新貼片利用微通道和軟性基板收集汗液和組織間液，並將生化訊號轉化為數位輸出，用於臨床和消費應用。它們的意義在於能夠實現傳統醫療環境以外的診斷，降低成本，並改善慢性病管理。從剛性微流體晶片到超薄黏附貼片的演變，使得血糖值監測、電解質監測和皮質醇評估等應用成為可能。隨著監管法規的不斷完善和成本的降低，該市場正擴展至慢性病護理和藥物依從性監測領域。此外，人工智慧驅動的訊號處理和模式識別技術的進步，提高了診斷精度，並催生了更有效的遠端監控解決方案。

全球皮膚微流體貼片市場促進因素

全球皮膚微流體貼片市場正受到軟性生物相容性感測材料進步的顯著推動。這些材料能夠改善皮膚接觸，實現可靠的體液採樣，並透過提高訊號保真度和使用者舒適度來加速此技術的應用。更薄、更柔韌的貼片可與低功耗電子元件無縫整合，即使在運動過程中也能保持微流體通道形狀的一致性。這種相容性延長了監測時間，並簡化了使用者操作。此外，更佳的黏附性和更低的皮膚刺激性降低了日常使用的阻力，從而提高了臨床應用和消費者的長期接受度。

全球皮膚微流體貼片市場面臨的限制因素

由於穿戴式診斷設備法規結構的複雜性和不斷演變，全球皮膚微流體貼片實驗室市場面臨許多限制因素。製造商需要應對不同的區域標準和證據要件，而全面的臨床評估和文件記錄要求導致產品上市時間延長。這種監管複雜性增加了開發商的資源需求和相關風險，阻礙了小規模公司進入市場，並限制了對創新設計的投資。因此，即使這些技術已準備好應用於臨床，但由於需要在各種使用情境中證明其安全性和分析效能，因此限制了其快速規模化生產，並阻礙了其廣泛應用。

用於皮膚應用的實驗室微流體貼片市場的全球趨勢。

全球皮膚微流體貼片市場正呈現顯著成長，這主要得益於以消費者為導向的設計理念，即優先考慮易用性和美觀性。材料和製造程序的創新，使得產品具有柔軟、可拉伸的特性和緊湊的形狀，從而確保使用者佩戴舒適。這些進展與簡化採樣流程的直覺式介面相輔相成，使該技術也適用於非臨床應用。人們對美觀性和隱蔽性設計的日益關注，促進了產品融入日常健康管理流程，擴大了潛在市場並促進了產品差異化。這一趨勢迎合了不同人群的需求，符合各種生活方式偏好，並最終推動了該技術在更廣泛的健康管理場景中的應用。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

20/20 GeneSystems
Eano Health
Dermalux
Trestle Biotherapeutics
My Skin Track UV
In Vivo Analytics
MC10
Episkin
Alimetry
Zeno Health
Pulsar Bioanalytics
Sway Medical
HemoCue
Bioengineered Applications
Sensei
Health Watchers
Biointelli
CareWear
Elysium Therapeutics
Mondrian Technologies

結論與建議

簡介目錄

Product Code: SQMIG35A3239

Global Lab-On-Skin Microfluidic Patch Market size was valued at USD 1.34 Billion in 2024 and is poised to grow from USD 1.57 Billion in 2025 to USD 5.68 Billion by 2033, growing at a CAGR of 17.4% during the forecast period (2026-2033).

The lab-on-skin microfluidic patch market is driven by the integration of miniaturized fluidics and the increasing need for continuous non-invasive physiological monitoring. These innovative patches utilize microchannels and flexible substrates to collect sweat or interstitial fluid, transforming biochemical signals into digital outputs for both clinical and consumer use. Their significance lies in enabling diagnostics outside conventional healthcare settings, reducing costs, and enhancing chronic disease management. The evolution from rigid microfluidic chips to ultrathin adhesive patches has paved the way for applications in glucose tracking, electrolyte monitoring, and cortisol assessment. As regulations evolve and costs decrease, the market expands into chronic care and drug adherence monitoring. Moreover, AI enhances diagnostic accuracy by improving signal processing and pattern recognition, leading to more effective remote monitoring solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lab-On-Skin Microfluidic Patch market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lab-On-Skin Microfluidic Patch Market Segments Analysis

Global lab-on-skin microfluidic patch market is segmented by product type, technology type, application, biomarker type, material type, end user, distribution channel and region. Based on product type, the market is segmented into Diagnostic Patches, Therapeutic Patches, Monitoring Patches and Others. Based on technology type, the market is segmented into Sweat-Based Microfluidics, Interstitial Fluid (ISF)-Based Microfluidics, Microneedle-Integrated Microfluidics, Electrochemical Sensing Technology, Biosensor-Integrated Systems and Others. Based on application, the market is segmented into Chronic Disease Monitoring, Glucose Monitoring, Lactate Monitoring, Electrolyte Monitoring, Hydration Monitoring, Infectious Disease Detection, Wound Care Management and Others. Based on biomarker type, the market is segmented into Glucose, Lactate, Sodium, Potassium, Chloride, Cortisol, pH and Uric Acid. Based on material type, the market is segmented into Polymer-Based, Paper-Based, Hydrogel-Based, Hybrid and Others. Based on end user, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings and Research Laboratories. Based on distribution channel, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lab-On-Skin Microfluidic Patch Market

The Global Lab-On-Skin Microfluidic Patch market is significantly driven by the advancements in flexible, biocompatible sensing materials that facilitate improved skin contact and reliable fluid sampling. These innovations enhance signal fidelity and user comfort, promoting wider adoption of the technology. Thinner and more conformable patches maintain consistent microfluidic channel geometry during movement while integrating seamlessly with low power electronics. This compatibility supports extended monitoring durations and simplifies user interactions. Furthermore, enhancements in adhesive performance and reduction of skin irritation lower resistance to routine usage, paving the way for greater clinical and consumer acceptance over the long term.

Restraints in the Global Lab-On-Skin Microfluidic Patch Market

The Global Lab-On-Skin Microfluidic Patch market faces significant restraints due to the intricate and evolving regulatory frameworks governing wearable diagnostic devices. Manufacturers encounter a myriad of regional standards and varying evidentiary requirements, which necessitate comprehensive clinical evaluations and documentation, thereby extending the time to market. This regulatory complexity heightens resource demands and associated risks for developers, often deterring smaller companies from entering the market and hampering investments in innovative designs. Consequently, the imperative to prove both safety and analytical performance across diverse usage scenarios restricts rapid scaling and hinders the widespread acceptance of these technologies, despite their readiness for clinical application.

Market Trends of the Global Lab-On-Skin Microfluidic Patch Market

The Global Lab-On-Skin Microfluidic Patch market is experiencing a significant upward trend driven by a shift toward consumer-friendly designs that enhance usability and aesthetic appeal. Innovations in materials and manufacturing processes prioritize soft, stretchable consistency and compact form factors, ensuring comfortable wear for users. These advancements are complemented by intuitive interfaces that simplify the sampling process, making the technology accessible for nonclinical applications. The growing focus on aesthetics and discretion encourages integration into daily wellness routines, thus expanding the potential market and fostering product differentiation. This trend caters to diverse demographics, aligning with varied lifestyle preferences and ultimately driving adoption in broader health management scenarios.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Technology Analysis
Case Studies
Value Chain Analysis

Global Lab-On-Skin Microfluidic Patch Market Size by Product Type & CAGR (2026-2033)

Market Overview
Diagnostic Patches
Therapeutic Patches
Monitoring Patches
Others

Global Lab-On-Skin Microfluidic Patch Market Size by Technology Type & CAGR (2026-2033)

Market Overview
Sweat-Based Microfluidics
Interstitial Fluid (ISF)-Based Microfluidics
Microneedle-Integrated Microfluidics
Electrochemical Sensing Technology
Biosensor-Integrated Systems
Others

Global Lab-On-Skin Microfluidic Patch Market Size by Application & CAGR (2026-2033)

Market Overview
Chronic Disease Monitoring
Glucose Monitoring
Lactate Monitoring
Electrolyte Monitoring
Hydration Monitoring
Infectious Disease Detection
Wound Care Management
Others

Global Lab-On-Skin Microfluidic Patch Market Size by Biomarker Type & CAGR (2026-2033)

Market Overview
Glucose
Lactate
Sodium
Potassium
Chloride
Cortisol
pH
Uric Acid

Global Lab-On-Skin Microfluidic Patch Market Size by Material Type & CAGR (2026-2033)

Market Overview
Polymer-Based
Paper-Based
Hydrogel-Based
Hybrid
Others

Global Lab-On-Skin Microfluidic Patch Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
Research Laboratories

Global Lab-On-Skin Microfluidic Patch Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Direct Sales
Distributors

Global Lab-On-Skin Microfluidic Patch Market Size & CAGR (2026-2033)

North America (Product Type, Technology Type, Application, Biomarker Type, Material Type, End User, Distribution Channel)
- US
- Canada
Europe (Product Type, Technology Type, Application, Biomarker Type, Material Type, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology Type, Application, Biomarker Type, Material Type, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology Type, Application, Biomarker Type, Material Type, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology Type, Application, Biomarker Type, Material Type, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

20/20 GeneSystems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eano Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dermalux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trestle Biotherapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
My Skin Track UV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
In Vivo Analytics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MC10
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Episkin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alimetry
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zeno Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pulsar Bioanalytics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sway Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HemoCue
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioengineered Applications
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensei
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health Watchers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biointelli
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareWear
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elysium Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mondrian Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments